Every day, a broiler’s intestine processes several times its body weight in feed and water, encounters billions of microorganisms, responds to environmental stress, and continuously decides what enters the body and what remains outside.

In many ways, the gut functions as a customs checkpoint, security system, digestive factory, and immune headquarters—all at the same time.

In fact, nearly 70% of the bird’s immune cells are associated with the gastrointestinal tract, making it a key player in both health and performance. The remarkable aspect is that when the gut is functioning well, nobody notices it. When it begins to fail, everybody notices the consequences.

The Modern Poultry Bird: Built for Speed
Today’s broiler is a biological marvel. Through decades of genetic selection, modern birds reach market weight faster and more efficiently than ever before.
However, this achievement comes with a hidden challenge.

The digestive tract has become one of the most critical performance-limiting organs in poultry production. Every gram of feed must be digested, absorbed, and converted into muscle within an increasingly compressed production cycle.

Twenty years ago, a small reduction in nutrient absorption might have gone unnoticed. Today, even minor intestinal inefficiencies can translate into measurable losses in body weight gain, feed conversion ratio, and profitability. Modern birds can no longer afford a lazy gut.

The Gut Is Constantly Making Decisions
Traditionally, we think of the intestine as a nutrient absorption organ.
In reality, the gut is making thousands of biological decisions every second.

– Should nutrients support growth or immunity?
– Should a microorganism be tolerated or eliminated?
– Should energy be invested in production or defense?
– Should the intestinal barrier remain open for absorption or tighten to prevent invasion?

These microscopic decisions ultimately determine flock performance.
In many ways, poultry production is not simply about feeding birds—it is about influencing the decisions being made within the gut.

The Hidden Cost of Inflammation
One of the most important concepts emerging in poultry science is that inflammation carries a nutritional cost.
Whenever the intestine encounters stress from pathogens, mycotoxins, heat, poor litter quality, or microbial imbalance, the immune system becomes activated.
The immune response is essential for survival, but it is expensive.
Energy that could support growth is redirected toward immune activity.
Amino acids that could build muscle are utilized to produce immune proteins and inflammatory mediators.
Vitamins and minerals become involved in tissue repair and antioxidant defense.
The bird continues eating, yet a significant proportion of nutrients may no longer be contributing to production.
This phenomenon is often referred to as the “hidden feed cost” of inflammation.

The Silent Performance Thief
One of the greatest misconceptions in poultry production is that intestinal problems always produce visible symptoms.
– Not necessarily.
– Many flocks show normal feed intake, acceptable mortality, and no obvious disease outbreaks. Yet they consistently fail to achieve target performance.
– A slight reduction in nutrient absorption.
– A minor microbial imbalance.
– A low level of intestinal inflammation.
– A subtle increase in intestinal permeability.
Individually these changes may appear insignificant. Collectively they can result in substantial economic losses. This is why gut health is increasingly viewed not as a disease issue but as a performance issue.

The Microbial Workforce Inside Every Bird
Perhaps the most fascinating discovery in recent years is the realization that birds are never truly alone.
The digestive tract contains trillions of microorganisms collectively known as the gut microbiome.
These microbes help digest feed ingredients, produce beneficial metabolites, support intestinal development, influence immune responses, and compete with harmful bacteria.
Some scientists now describe the microbiome as an additional organ because of its profound influence on bird health.
This raises an interesting question:
Are we feeding the bird, or are we feeding its microbiome?
The answer is both.
The future of poultry nutrition may depend as much on managing microbial populations as on balancing nutrients.

Heat Stress: The Gut’s Greatest Enemy
In many poultry-producing regions, heat stress has become one of the most significant challenges affecting gut health.
High environmental temperatures reduce blood flow to the intestine, increase oxidative stress, and compromise intestinal barrier integrity.
As a result, harmful bacterial toxins can cross the intestinal wall and trigger inflammation.
Often the first casualty of heat stress is not growth—it is gut integrity.
This may explain why heat-stressed flocks frequently show poorer FCR, increased wet litter, reduced nutrient utilization, and greater disease susceptibility.
As global temperatures continue to rise, protecting gut health during periods of heat stress will become increasingly important.

The Gut in the Antibiotic-Free Era
The poultry industry is rapidly transitioning toward antibiotic-free and reduced-antibiotic production systems.
While this shift addresses consumer concerns and regulatory requirements, it has also increased attention on intestinal health.
Without routine antibiotic growth promoters, producers must rely on alternative strategies to maintain gut stability.
Probiotics, prebiotics, β-glucans, mannan oligosaccharides (MOS), organic acids, phytogenic compounds, and postbiotics are increasingly being used to support intestinal resilience and microbial balance.
The focus is shifting from killing pathogens to creating an intestinal environment where beneficial microbes and the host can thrive together.

More Birds or More Protein?
The global poultry industry is not being asked to produce more birds.
It is being asked to produce more protein.
As the world’s population grows and consumers increasingly seek affordable animal protein, poultry production continues to expand. Industry projections estimate the sector will grow at a CAGR of approximately 5–7% over the coming years.

But growth alone is not enough.
Producers are expected to deliver more meat with fewer resources, lower feed costs, and a smaller environmental footprint.
This means that every gram of feed matters more than ever before.
And that brings us back to the gut.
Because the difference between feed consumed and protein produced is ultimately determined by the efficiency of the digestive system.

The Future Begins in the Gut
For decades, poultry production focused on genetics, nutrition, and disease control.
The next frontier may be intestinal resilience.
Future improvements in productivity will likely come from better management of inflammation, enhanced barrier integrity, optimized microbiomes, and improved nutrient efficiency within the gastrointestinal tract.
The question may no longer be:

“How much feed did the bird consume?”

Instead, the more important question may be:
“How much of that feed actually became growth?”
The answer lies within the gut.
Not because it is merely another organ, but because it is the organ that determines how effectively all the others perform.
In an era of narrow margins, rising feed costs, heat stress, and antibiotic-free production, the healthiest gut may ultimately become the most valuable asset in the poultry house.

It was a pleasure to visit the Gurgaon office of Dovoy Chemicals India Pvt. Ltd., a biotechnology-driven company that has been delivering innovative solutions to industries worldwide. With a strong presence across Asia, Africa, and the Middle East, Dovoy has established itself as a trusted partner in animal health, nutrition, grain processing, food ingredients, and industrial solutions.

During my visit, I had the opportunity to interact with Mr. Amit Kaushik, Director, Dovoy Chemicals India Pvt. Ltd.; Mr. Duttle Bing, General Manager – ASPAC & EMEA, Dovoy Inc. Singapore; Dr. Vipul Gohel, Director, MIV Biosolutions and Channel Partner for Dovoy; Mr. Anand Singh, Business Head – Animal Health; Dr. Sumit Raja, Technical Manager – Animal Health; Mr. Shyam Sunder Sharma, Business Head – DGP; Ms. Dhanashri Shitole, Zonal Sales Manager-South & Maharashtra and Ms. Akanksha Sethi, Dovoy.
Mr. Amit Kaushik highlighted that what truly differentiates Dovoy is its unwavering commitment to innovation, research, and quality. The company operates advanced ISO 17025:2017 accredited laboratories where product development, quality assurance, enzyme assays, thermostability testing, and customized solution development are carried out to meet the evolving needs of modern industries.

Mr. Kaushik further emphasized that Dovoy’s vision extends beyond supplying products. The company is focused on delivering holistic solutions and value-added services to customers. Complimentary amino acid profiling services, supported by their ISO 17025:2017 accredited laboratory, provide customers with greater confidence in feed quality and nutritional accuracy. Dovoy’s state-of-the-art laboratory is equipped with sophisticated technologies including the Agilent HPLC 1260, advanced spectrophotometers, Kjeldahl Distillation systems, Class-II Biosafety facilities, biodigesters, and Neogen Raptor platforms. These capabilities support quality assurance and the development of innovative biotechnology solutions across multiple sectors.

According to Mr. Shyam Sunder Sharma, Dovoy’s expertise in proximate analysis, protease enzyme thermostability testing, aflatoxin reduction solutions, microbial load analysis, amino acid profiling, and advanced enzyme assay testing provides a significant competitive edge. The company adheres to globally recognized standards including ISO, GMP, REACH, Halal, FSSAI, Kosher, ZDHC, and D&B certifications.

In the Animal Health & Nutrition sector, Dovoy offers a comprehensive portfolio of feed additive solutions including enzymes, organic trace minerals, yeast-based products, antioxidants, immune modulators, gut health solutions, toxin binders, acidifiers, and lipid metabolism enhancers. These technologies are designed to improve nutrient utilization, gut health, productivity, and overall farm profitability, as shared by Mr. Anand Singh and Dr. Sumit Raja.

The visit was followed by an engaging podcast hosted by Ms. Dhanashri Shitole and Ms. Akanksha Sethi, where I shared my thoughts on the “Future of the Indian Poultry Feed Industry.” I look forward to its release of this Podcast in the coming days.

The visit provided valuable insights into how biotechnology, innovation, and scientific excellence are shaping the future of animal nutrition and sustainable livestock production. It was inspiring to witness Dovoy’s commitment to developing practical, performance-oriented solutions backed by robust research and field validation.

PIONEERING ANIMAL HEALTH THROUGH PHYTOGENIC INNOVATION

France Based IDENA’s Complex Phytogenic Animal Nutrition Products Through Feed Development has led to Higher Productivity and Better Animal Health – Ricky Thaper (www.rickythaper.com)

Improving livestock health has been recognized by producers as an important sustainability effort which improves efficiency and reduces productivity losses in the animal husbandry sector. The United Nations Food and Agriculture Organisation (FAO) has urged nations to integrate animal health into their national climate commitments, calling it “vital for sustainable livestock production.” The roadmap recognized the importance of livestock to 1.7 billion farmers worldwide and offered proven pathways for addressing its climate footprint including better genetics, feed, and animal health. An UN report calculated the effects of different steps to address livestock emission by stating that animal productivity increase would reduce emissions 20%. It also stated that feed improvements by 12%, better animal health by 10%, improved genetics by 8% and methane reducing feed additives by 5%.

This growing recognition of the value of animal health and related technologies has the potential to boost livestock sustainability and decrease its carbon footprint. This will require adoption of strong biosecurity protocols, improved feed and use of good additives, better breeding practices and adoption of new digital technologies. Keeping this vision in mind, several companies have been working towards boosting animal health and productivity through development of innovative products keeping into consideration the unique needs of countries across the world.

Since its creation in 1995, France based global major in animal nutrition IDENA group has developed products keeping into account the nutritional needs of poultry, dairy, and piggery. The key focus of the IDENA is to introduce innovative additives and pre-mixes which boost the poultry and livestock feed and increase performances of poultry and livestock in the farms.

At IDENA, head-quartered in SAUTRON, Pays de la Loire, France, there are experts who are passionate about developing products which promote animal growth and welfare. IDENA’s technical and sales teams, often in the field, offers tailor-made advice to improve the formulation of products and optimise their effectiveness depending on the needs of the customer. The company has succeeded in establishing its fundamentals and convictions in the animal nutrition market, developing them and continuing to build on them. In 2001, the IDENA production plant in Pontchâteau, France was set up.

The mission of the company is to market natural alternatives to conventional additives in order to reduce the use of antibiotics and preserve their effectiveness (antibiotic resistance). These alternatives are made up of phytogenic, bioactive and active ingredients derived from lactic fermentations through IDENA’s sister company STI BIOTECHNOLOGIE which has developed a unique range of Postbiotics.

Following a specific inactivation process, STI Biotechnologie manufactures, among other products, a postbiotic solution, available in powder and liquid form. METALAC promotes digestive comfort, enhances animal welfare, and improves the animals’ immune status.

The company has numerous scientific publications: S. Jansseune’s thesis, published last June, expanded knowledge of METALAC through in vitro and in vivo experimental trials, as well as on the composition of metabolites synthesized during bacterial fermentation. The postbiotic contributes to the formation of a beneficial bacterial biofilm to protect intestinal villus cells, thereby strengthening the intestinal barrier. This research is continuing with a postdoctoral fellowship in collaboration with the University of Rennes, supervised by Monogastric Product Manager Maeva JEGOU.

Under the leadership of Director Christophe TANGUY, the Asia-Middle East region is managed by David CHEREL, based in China.

IDENA has also developed a complete range of nutritional specialities to improve the feed efficiency of animals fed in organic farming systems and these products are all approved by official organic farming certification bodies.

IDENA has a range of poultry products, among them; FORCIX PY (Prevention of the risk associated with Eimeria together with Necrotic Enteritis), FORKEY LS (Prevention of the risk associated with Histomonas in Turkeys), EVOPERF (Digestive comfort and performance), PONTIPLUS (Supporting hen productivity and longevity by maintaining laying rate and improving egg quality and breeders’ eggs hatchability) and IDAFIX+ (a large spectrum powerful mycotoxin binder). All these poultry products are based on the results of extensive scientific research, particularly into the action of plant extracts and essential oils. The issues studied relate mainly to make better use of the nutrients supplied and managing the risks of parasites and bacteria amongst the poultry birds. In poultry, IDENA focus is on gut health, mineral balance, feed efficiency, and resilience of birds under commercial conditions. IDENA solutions combine R&D, field validation, and practical formulation expertise to ensure both technical efficiency and economic viability. The nutrition experts in the company have developed a range of products designed to improve the feed efficiency of ruminants, focussing on critical components – protein, energy and fibre. The company also focussed on pig production for creating formulation through feed recipes and increase digestive efficiency of the animals.

To design animal feeding in different ways and to improve technical and economic performance while respecting animal welfare and the environment, IDENA develops quality feed products for the various sectors of the livestock economy- feed manufacturers, premix manufacturers, integrators, hatcheries, dairies, farms and breeders. The products are developed by consultants specialised by species. The IDENA group is made up of departments covering areas such as research and development, animal nutrition engineering and the manufacture of premixes and innovative specialities. This enables each entity to focus fully on its core business, whilst benefiting from the Group’s stability, experience and long term vision.

110 people are currently cooperating at IDENA, with Mr. Renaud Domitile as CEO and Mr. Massoud Aoun as General Manager. The commercial team is led by Mr. Franck Vaillant, Commercial Director, with 6 Regional Export Managers to cover the 5 continents.

Team of experts from the group also carry out on-farm audits to better adapt the formulation and use of additives to the context of each livestock farm. Six people are offering technical support for poultry: Mrs. Anne MAHIEU, Nutritionist-Head of Poultry Department, Dr. Jean-Marie WATIER- Vet Poultry Specialist, Ms. Amandine CANIN-Poultry Nutritionist Engineer, Mr. Khalil AOUAD, Poultry Nutritionist Engineer, and Mr. Bohdan BODNAR, Poultry Nutritionist Engineer, and also Mr. Renaud Domitile, CEO which is recognized worldwide for his nutrition expertise.

The 2000s saw the internationalisation of the Group’s activities. The company offers its services to hundreds of customers, both feed manufacturers and players in the animal sector, spread across France to more than 60 countries spanning five continents. It has succeeded in establishing its fundamentals and convictions in the animal nutrition market, developing them and continuing to build on them.

The Group has a robust central structure, which ensures strategic consistency, supports the development of its subsidiaries and fosters synergies between areas of expertise. The company’s annual revenue was approximately €50 million in 2025

With the future collaboration with Distributors in India, IDENA group has great plans to expand its presence in India, which has the world’s biggest livestock population said Mr. Renaud Domitile, CEO. The India poultry market is driven by strong demand for affordable animal protein and rapid industry structuring. However, it remains a highly competitive and price-sensitive market, where solutions must combine technical performance with clear economic return added Mr. Khalil AOUAD, Poultry Nutritionist Engineer.

Mr. Franck Vaillant, Commercial Director said through IDENA product innovation, India’s poultry and livestock sector will be immensely benefited to better feed and increase in productivity because of improvement in animal health. IDENA’s strength compared to most of its competitors lies not only in the fact that the company offers a range of innovative phytogenic products designed to improve feed efficiency and livestock performance, but that this offering is backed by extensive expertise in animal nutrition, feed formulation and livestock management, which IDENA’s teams make available to their partner clients.

For further information about IDENA poultry, dairy and piggery products, kindly visit IDENA Website: http://www.idena.fr/

Dr Eckel Animal Nutrition GmbH & Co. KG, Germany, a global animal nutrition specialist company organised World Tour 2026 Conference at Hotel Avani Riverside, Bangkok on March 14, 2026 which was attended by 90 over delegates from 12 countries which was addressed by eminent speakers.

In the year 1994, Dr. Antje Eckel, CEO, founded the company Dr. Eckel Animal Nutrition, aimed at ensuring animal nutrition is healthier, more animal-friendly and more sustainable. Over the next three decades, the family business grew into a globally successful provider of alternative animal feeding solutions. Other key persons associated with the company are Dr. Bernhard Eckel, Vice President – Sales, Dr. Viktor Eckel, Managing Director-Products and Innovation, Mr. Theo Eckel Head-Purchase and Ms. Klara Eckel, Product Manager.

World Tour 2026 Conference started with the opening remarks by Dr. Andreas Lewke, Managing Director (Thailand) Dr. Eckel Animal Nutrition. Dr Andreas Lewke has more than two decades of experience in Asia and a strong focus on sustainable, innovative animal nutrition. Dr. Eckel Animal Nutrition from their Bangkok office, the team has worked closely with integrators, feed mills and farmers across Asia and their main interest is how innovative, sustainable nutrition concepts can support both healthy animals and healthy profits. Dr. Andreas Lewke said today

Dr. Eckel Animal Nutrition is one of the international specialists for phytogenic solutions based on plant-derived active ingredients and their products are used in poultry, swine, ruminant and aquaculture nutrition around the world. The aim is always the same: to help the customers achieve direct and long-term success with healthy growth, high-quality products and efficient, resource-friendly production.

Dr. Viktor Eckel, Managing Director, Dr. Eckel Animal Nutrition in his keynote address highlighted “Plants Paving the Way for Future Animal Nutrition.

From the very beginning Dr. Eckel Animal Nutrition has focused on innovative feed additives that combine animal health, performance and sustainability. Dr. Viktor Eckel continues to shape the future of plant-based solutions and next-generation feed additives for animal nutrition. countries on almost all continents. He said the company’s products are manufactured in Germany to the highest quality standards. More than 75% of the raw materials requirement are sourced from European Union countries thus ensuring shorter supply routes and flexible manufacturing processes. Experts associated with the company from more than 20 countries are working towards ensuring the company’s growth.

After Coffee Braek, Dr. Anne Möddel, Team Lead Technical Sales, Dr. Eckel Animal Nutrition gave presentation on “Choosing the Right Phytogenic Solution to Achieve Your Goals”. At Dr. Eckel, Dr. Anne Möddel serves as a key technical contact for sales teams, partners and customers, providing in-depth expertise on phytogenics and monogastric nutrition. Her nice presentation was followed by Lunch.

Post Lunch, Dr. Nancy Salamanca, DVM, Ph.D., Independent Consultant & Professional Lecturer gave presentation on “Making Antibiotic-Free Farming Work: A Nutritionist’s Perspective”. Dr. Nancy Salamanca highlighted the importance of targeted feed solutions, gut health management, and practical nutritional approaches that help producers maintain animal performance while reducing reliance on antibiotics.

Dr. Le Van Phan, DVM, PhD, Assoc. Professor, Department of Microbiology and Infectious Disease, College of Veterinary Medicine, Head. Laboratory of Viral Infectious Diseases, Center for Research Excellence and Innovation, Vietnam National University of Agriculture gave update on ASF outbreaks in Vietnam (2019–2025) – Insights and Lessons Learned. It was privilege to hear the insights and research contributions of eminent Speakers.

Dr. Bernhard Eckel, Vice President, Dr. Eckel Animal Nutrition spoke on “Closing Reflections & Future Outlook”. Dr. Bernhard said their company has a motto – act local and think global. Dr. Eckel Animal Nutrition establishes sustainable social and ecological conditions across its product value chains as its products are sold globally and have wide footprints. By embracing such innovations, Dr Eckel protects the livestock but also contributes to a healthier, more efficient, and eco-friendly agricultural future for the world. The company participates in all the global livestock and poultry events for expanding outreach of its unique products.

Events like this truly highlight the value of global collaboration, knowledge sharing and industry connections. It was nice opportunity for me to learn, connect and exchange practical knowledge with professionals from many countries. Thanks to Dr. Eckel Team and the speakers for creating such an important global platform for knowledge sharing.

Launch of Advanced Mycotoxin Management Solutions – Antox Plus & Antox Precise
Nanovet Nutrition Pvt. Ltd., a fast-growing and innovation-driven animal nutrition company in India, proudly announces its strategic collaboration with nu.ance Biotechnology, Switzerland, a global leader in science-backed mycotoxins management solutions. This partnership marks a significant milestone in Nanovet’s journey to bring globally validated, high-performance nutritional technologies to the Indian poultry industry.

As part of this collaboration, Nanovet Nutrition has introduced two advanced toxin-management solutions to the Indian market—Antox Plus and Antox Precise.

Antox Plus offers comprehensive protection by targeting Mycotoxins, Endotoxins, and Chemical toxins, addressing the broader spectrum of feed-borne challenges.

Antox Precise is a highly selective solution dedicated exclusively to mycotoxin management, ensuring precise binding without compromising essential nutrients.

Together, these innovations strengthen feed safety, support animal health and performance, and enhance profitability for farmers and integrators.

Successful Multi-City Launch Events Across India
To mark the official launch of Antox Plus and Antox Precise, Nanovet Nutrition successfully conducted a series of launch events across three strategic poultry hubs in North India. These events witnessed enthusiastic participation from poultry farmers, integrators, veterinarians, consultants, distributors, and industry professionals.
Launch Event Details
· 15th December – Karnal
Venue: Vivaan Hotel, Karnal
· 17th December – Pathankot
Venue: Zone by The Park, Pathankot
· 19th December – Lucknow
Venue: Holiday Inn, Lucknow

Each event served as a dedicated knowledge-sharing platform focusing on Mycotoxin, Endotoxin and Chemical toxin risk management, field challenges, and innovative nutritional interventions aligned with Indian feeding practices.

Strong Technical Leadership & Global Expertise
The launch programs were successfully conducted by the Nanovet Nutrition team, led by experienced technical and commercial professionals who shared valuable insights on Toxins prevalence, impact on poultry performance, and the scientific advantages of Antox Plus and Antox Precise.

Nanovet Nutrition Team
· Dr. Deepak Singh – Technical Director
· Dr. Karthiga Kesavan– Product Manager
· Deepak Solanki- Regional Sales Manager-North
· Dr. Anirudh Ahlawat- Technical Service Manager- North
· Dedicated regional sales team members

nu.ance Biotechnology Team
· Dr. David Harrington – Chief Product Officer
· Mr. J. S. Uppal – Business Director, South Asia
Their presence reinforced the strength of the collaboration and highlighted nu.ance’s commitment to supporting Indian poultry producers with proven, research-driven solutions.

Antox Plus & Antox Precise – Science That Delivers Results
Antox Plus and Antox Precise are formulated using advanced adsorption and biotransformation technologies, developed through extensive global research and validated under diverse field conditions.

Key benefits include:
· Broad-spectrum Mycotoxins, Endotoxins and Chemical Toxins binder.
· Improved gut health and nutrient utilization.
· Enhanced flock performance and consistency.
· Reduced economic losses linked to mycotoxins.
These products are specifically adapted to Indian raw material variability, making them reliable solutions for modern poultry challenges.

Strengthening Nanovet’s Commitment to the Indian Poultry Industry
The successful execution of the multi-city launch events reflects Nanovet Nutrition’s strong field connect, technical capability, and commitment to delivering value-driven solutions. The collaboration with nu.ance Biotechnology further strengthens Nanovet’s product portfolio and reinforces its position as a trusted partner for poultry producers across India.

Nanovet Nutrition continues to focus on innovation, quality, and farmer-centric solutions, bridging global science with local expertise to support sustainable and profitable animal production.

Nanovet Nutrition Pvt. Ltd. – Turning Ideas into Innovations.

Nanovet Nutrition Private Limited, a fast-growing, science-driven animal health and nutrition company, announced a strategic collaboration with nu.ance Biotechnology, Switzerland, during Poultry India. This partnership marks a significant milestone in Nanovet’s journey to strengthen its global scientific footprint and deliver advanced, research-backed solutions to the Indian livestock industry.

About Nanovet Nutrition Pvt. Ltd.
Nanovet Nutrition Private Limited is committed to enhancing livestock productivity, animal welfare, and farm profitability through innovative, technology-driven nutritional solutions. The company has established strong expertise in veterinary nutraceuticals, gut health enhancers, feed quality solutions, and biosecurity technologies, addressing the evolving needs of the poultry, ruminant, swine, and companion animal sectors.

Headquartered in Bengaluru, India, Nanovet integrates research, innovation, sustainability, and customer-centric development to deliver measurable performance outcomes for producers. Through continuous investment in science and strategic global collaborations, Nanovet is rapidly emerging as a progressive and reliable partner in animal nutrition and health. Under the visionary leadership of Mr. Sanjeev Khanna, Managing Director, Nanovet Nutrition has witnessed accelerated growth and industry recognition. With deep domain expertise and a strong focus on innovation, Mr. Khanna has steered the company toward adopting advanced technologies, strengthening scientific alliances, and building long-term value for customers and stakeholders. His leadership continues to position Nanovet as a future-ready organization aligned with global best practices.

Strategic Collaboration with nu.ance Biotechnology, Switzerland


As part of its commitment to bringing world-class science to India, Nanovet has entered into a strategic collaboration with nu.ance Biotechnology, a Switzerland-based biotechnology innovator renowned for its advanced nutritional technologies and mycotoxin management solutions.

nu.ance Biotechnology brings strong global credentials, including:
– A state-of-the-art production facility in France
– Commercial presence across 40+ countries
– Specialized expertise in postbiotics, globa.biotics, feed additives, and next-generation nutritional technologies.

This collaboration significantly enhances Nanovet’s technical capabilities and supports the introduction of high-performance, research-validated feed solutions tailored to the needs of Indian and neighboring markets.

Leadership Presence at the Collaboration Event
The collaboration was formally reinforced during a dedicated event at Poultry India, attended by senior leadership from both organizations. The Nanovet delegation was led by:
– Mr. Sanjeev Khanna, Managing Director
– Dr. Deepak Singh, Technical Director
– Mr. Avinash Kharat, National Sales Head
– Along with members of the commercial and technical teams.

nu.ance Biotechnology was represented by:
– Dr. David Harrington, Chief Product Officer
– Mr. J. S. Uppal, Business Director – South Asia.
The presence of senior leadership underscored the shared commitment of both companies toward innovation, knowledge exchange, and long-term market development.

Nanovet × nu.ance: A Future-Focused Partnership
Through this collaboration, Nanovet Nutrition aims to leverage nu.ance Biotechnology’s global expertise in biotechnology, formulation science, and quality systems to further enhance product performance and deliver superior value to customers. Together, both organizations are aligned in their vision to introduce globally benchmarked, sustainable, and performance-oriented innovations for the livestock industry.

This strategic alliance reinforces Nanovet Nutrition’s position as a science-led, globally connected partner, dedicated to shaping the future of animal nutrition in India and beyond.

During my interaction with Dr. Andreas Lewke, Managing Director (Thailand) at Dr. Eckel Animal Nutrition, Germany, I gained valuable insights into how phytogenic feed additives and sustainable nutrition strategies are shaping the future of poultry production and why India remains a key growth market for science-based nutrition solutions. With over two decades of experience across Asia, Dr. Lewke has worked closely with poultry integrators, feed mills and nutritionists to improve gut health, feed efficiency, bird robustness and profitability through plant-derived active ingredients. Our discussion highlighted how these phytogenic solutions can help Indian poultry producers address challenges such as feed cost volatility, disease pressure, heat stress and reduced antibiotic use, while delivering measurable long-term value.

Ricky Thaper: For our readers in India, could you briefly introduce Dr. Eckel Animal Nutrition?
Dr. Andreas Lewke: Dr. Eckel Animal Nutrition is a family-owned company from Germany, founded more than 30 years ago. From the very beginning we have focused on innovative feed additives that combine animal health, performance and sustainability. Today we are one of the international specialists for phytogenic solutions based on plant-derived active ingredients. Our products are used in poultry, swine, ruminant and aquaculture nutrition around the world. The aim is always the same: to help our customers achieve direct and long-term success with healthy growth, high-quality products and efficient, resource-friendly production.

” Phytogenic nutrition isn’t a concept for tomorrow—it’s delivering performance, health and profitability in poultry production today.”

– Dr Andreas Lewke

Ricky Thaper: What makes Dr. Eckel’s solutions particularly relevant for poultry producers in a market like India?
Dr. Andreas Lewke: In many markets, advanced feed additives are sometimes still seen as “nice to have” products. Our experience in Asia shows that, under today’s competitive conditions, they are much more than that: in fact, they are important tools for securing performance and profit.

Our phytogenic products support gut health, feed efficiency and overall robustness of the birds, whether by helping them cope with stress, pathogen pressure or by diminishing the burden of endotoxins. Together, these concepts help producers to get more value from every kilogram of feed, to stabilise performance under challenging conditions and to protect product quality, while supporting strategies to reduce the reliance on antibiotics and to respond to customer expectations for safe, high-quality poultry meat and eggs. We know that Indian poultry professionals already run very sophisticated operations. Our goal is to offer solutions that fit into these systems and add measurable value where it matters most.

Ricky Thaper: Could you tell us a bit about your own role and background?
Dr. Andreas Lewke: I am Managing Director of Dr. Eckel Animal Nutrition in Thailand and responsible for our activities in Asia. I have been working in the region for more than 20 years, always in the field of animal nutrition and feed additives. Over the years I have worked closely with integrators, feed mills and farmers across Asia. My main interest is how innovative, sustainable nutrition concepts can support both healthy animals and healthy profits.

Ricky Thaper: How do you see your connection to the Indian poultry sector in particular?
Dr. Andreas Lewke: India is a key part of our Asian focus. The scale, professionalism and speed of development in the Indian poultry industry are impressive. Over the years I have had many discussions with Indian colleagues at conferences and during customer visits in the region.

What I see is a very strong base of local expertise and entrepreneurial spirit. Indian poultry professionals are highly knowledgeable and very open to new ideas, but they rightly expect clear evidence and practical benefits. They ask tough, practical questions: does it work in my conditions, is it economic, does it help me secure my business in the long run? This mindset fits very well with how we work at Dr. Eckel.

Ricky Thaper: From your perspective, how would you describe the Indian poultry industry today – its strengths and its main challenges?
Dr. Andreas Lewke: India is already one of the largest poultry producers in the world and still has significant growth potential. Rising incomes, urbanisation and changing food habits are driving demand for affordable, high-quality animal protein. Poultry is often the first choice because it is accessible, versatile and fits well with consumer preferences.

At the same time, the industry needs to manage several challenges. Feed raw materials can be expensive and volatile, so producers need to get the maximum value from every ration. Disease pressure and biosecurity are constant topics, especially in high-density production areas.
There is also a clear move towards reducing antibiotic use and towards more sustainable, welfare-orientated production systems that make better use of resources. For us, this combination of strong market growth and pressure on costs and resources makes India not only one of the most important poultry markets globally but also one of the most inspiring to work with.

Ricky Thaper: In this context, how do you see Dr. Eckel contributing to Indian poultry in the coming years?
Dr. Andreas Lewke: We see our role as a trusted partner. Our task is to contribute proven tools and know-how that support the goals Indian companies have set for themselves. In practical terms, this means working to implement phytogenic concepts that fit Indian conditions. Our products support better gut health, more stable performance and consistent meat and egg quality, even under heat or pathogen stress and other challenges.

With our experience in the phytogenic sector, our solutions that unite profit, health and quality, our innovative portfolio and our flexible, customer-orientated service, we believe we can make a meaningful contribution to the continued success of the Indian poultry sector.

Ricky Thaper: Finally, what message would you like to share with Indian poultry professionals who are reading or watching this interview?
Dr. Andreas Lewke: First of all, I have great respect for what the Indian poultry industry has achieved. Indian poultry industry has built a strong, dynamic sector that keeps moving forward despite many external challenges. My message would be : “We at Dr. Eckel are keen to learn from Indian poultry industry leaders experience and to share our own expertise where it can help. If Indian poultry industry is interested in practical, sustainable nutrition concepts that support healthy growth, product quality and long-term success, we would be very happy to exchange ideas and explore how we can work together.”

-Ricky Thaper (www.rickythaper.com)

39th edition of SPACE 2025 organised from September 16 to 18, 2025 at the Rennes Exhibition Centre, in Rennes, western France, a leading livestock-producing region in Europe was a grand success. SPACE Exhibition is a premier platform for professionals across the poultry, dairy, swine and aquaculture sectors to explore and discuss advancements in animal farming. SPACE 2025 Exhibition featured over 1230 exhibitors from 40 countries and 1,02,000, visitors from 125 countries showcasing innovations across 11 sector-specific halls and a 16-hectare outdoor exhibition area. Mr. Didier Lucas, the new President of SPACE, highlighted the show’s role as a bridge between innovation and the future of sustainable livestock. Ms. Ane Marie Quemener, General Commissioner of SPACE, emphasized the exhibition’s mission to address global challenges in animal farming while strengthening international collaboration. Ms. QUEMENER, added that the efforts and hard work by SPACE Team has given excellent results.

At NU.ANCE Biotechnology booth, I had good meeting with Dr. Nemanja Todorovic, Chief Business officer, NU.ANCE Biotechnology is specialised in development and commercialisation of innovative feed additive products, merging expertise in technical and scientific knowledge. Mr. Joginder Singh, Uppal, Business Director, is very efficiently heading the NU.ANCE Biotechnology business in India and other South Asian Countries.

During SPACE Exhibition, it was nice to meet and interact with Dr. Bernhard Eckel, Vice President–Sales, Dr. Eckel Animal Nutrition GmbH & Co. KG, based in Niederzissen, Germany. Over the past three decades, Dr. Eckel has grown from a family business into a globally recognized provider of alternative feeding solutions and has become one of the global leaders in sustainable animal nutrition.

Ms. Cecile Berthier, International Press and Exhibitors Information, highlighted the importance of giving visibility to such innovations, enabling exhibitors to gain recognition and enhance global reach. Poultry and Dairy Farms visits were also arranged for the international visitors. SPACE 2025 is fostering innovation, collaboration and growth within the global livestock and poultry sectors.

At Biochem booth I had good interaction with Mr. Niels Otto Damholdt, Sales Director, Biochem. The Company headquarter is located in the northwest German town of Lohne, supplying high quality feed additives for poultry and livestock. Dr. Bhaskar Choudhry is heading the Biochem business in India which has good growth in terms of volumes and sales.

It was nice to meet Mr. Xavier Cadiou, CEO of Agri Reseaux International and VIV worldwide partner for France at his booth during SPACE 2025. Mr. Cadiou updated that he is working on the participation of French companies at VIV Select India 2026 being organised at Yashobhoomi, New Delhi, from April 22-24, 2026.

Amandine Leroux, International Development, SPACE, reiterated the importance of building meaningful international partnerships through knowledge-sharing and collaborative discussions.

The International Club being supported by Bretagne Commerce International, Business France, and BPI France, has provided a dedicated space for international visitors and exhibitors to do networking, conduct business meetings and explore partnership opportunities.

Tailored farm visits also being organized for international delegates said Ms. Chloe Letellier, Communication Press, SPACE. During SPACE 2025, I attended conference and symposia on poultry and livestock, covering topics such as environmental assessment in poultry farming, dairy farming, aquaculture and the application of artificial intelligence in livestock and agriculture. These sessions provided actionable insights and practical solutions tailored to the evolving needs of the agricultural sector.

At Aviagen booth, I met Mr. Florian Blevin, International Commercial Manager SSA, Aviagen Limited and had good interaction.

At Novogen booth, I had good interaction with Mr. Stephane Lemoine, Director, Business Development, Novogen along with Mr. Vaibhav Aghi, Director, Aghi Group, Dr. SK Bhardwaj and other delegates from India. AGHI Group’s Easy Poultry Innovation LLP has partnered with global poultry genetics leader Novogen to introduce the Novogen layer breed in India from 2026, marking a significant milestone for the country’s poultry sector. Mr. Vaibhav said their collaboration with Novogen aims to provide Indian farmers with a high-performing layer bird known for excellent laying persistency, uniform egg quality, and efficient feed conversion. Combining Novogen’s global expertise with AGHI Group’s local network and farmer-focused approach, the partnership seeks to drive sustainable, profitable, and high-quality egg production in India.

One of the International visitor visiting the show, said “As a key platform for international trade, SPACE emphasizes energy conservation, bio-security, and veterinary advancements, making it indispensable for professionals from Poultry and Dairy Industry, globally. It’s truly the “Livestock Planet.” Another International visitor said great success at SPACE Exhibition! Inspiring innovations, valuable connections, and unforgettable experiences. Glad to know that SPACE Exhibition exceeded expectations! Thanks to organizers, exhibitors, and visitors especially a large content of Indian visitors for making it happen. While interacting with exhibitors, they rated SPACE as very high quality trade show. In the evening attended the Reception organised by SPACE for the Press and their VIP delegates which was addressed senior officials of SPACE Team.

The next edition of SPACE is scheduled for September 15–17, 2026, at the Rennes Exhibition Centre, Rennes, France.

Dr. Stéphanie Ladirat, R&D Director, NUQO

A recent research program highlights that micro-encapsulation of seaweed and plant extracts can stimulate digestive functions, improve performance, and reduce feed costs, addressing current egg industry needs.

The egg industry grapples with key challenges in optimizing nutrition and profitability for laying hens. One significant hurdle involves efficiently producing eggs while maintaining bird health and well-being. Sustainable practices, such as efficient waste management and reducing the environmental footprint, are essential to address growing concerns about the environmental impact of egg production. To tackle these issues and enhance the performance of laying hens, strategies have emerged. These include formulating balanced diets with alternative protein and energy sources, exploring feed additives like enzymes, microbials, phytogenics, and seaweed extracts. Enzymes, such as phytase, improve nutrient utilization, while probiotics and prebiotics support gut health, enhancing feed conversion and disease resistance. Natural phytogenics provide antioxidants, affect the microflora profile, and improve digestive functions, ultimately leading to increased egg production and improved egg quality. Seaweed bioactives (so called-phycogenics), contribute as well to better gut health of animals. These strategies address challenges in egg production and meet consumer expectations for high-quality, nutritious eggs, all while promoting sustainable and eco-friendly practices.

The latest benchmark for phytogenic feed additives
Lately, a feed additives company has introduced an innovative product, NUQO©NEX (NQ), comprising metabolites sourced from both plants and algae (referred to as phytogenic and phycogenic, originating from the Greek words ‘phytos’ for plant and ‘phycos’ for algae). These metabolites are shielded by a unique micro-encapsulation technology. The utilization of micro-encapsulation has become imperative in the realm of phytogenic feed additives to mitigate the volatility of natural compounds. While the term ‘encapsulation’ is increasingly generic, it is crucial to discern authentic technology that not only safeguards but also effectively releases active ingredients, setting it apart from rudimentary methods like silica absorption or light-agglomeration, which may suffice for various compounds but fall short in preserving delicate phytogenics like essential oils.

It is of utmost importance to delve into the manufacturing technology underpinning each product, rather than solely relying on surface-level claims. With its notably high concentration of active components and remarkable stability, this novel solution assures a precise release in the digestive tract and offers a cost-effective dosage unlike any other currently available. This technology has been meticulously developed to optimize poultry performance and can serve as an alternative growth promoter or a means to enhance feed conversion ratios and overall performance, ultimately resulting in an improved return on investment for poultry operations.

Numerous trials have validated the effectiveness of this technology in enhancing the performance of laying hens across diverse contexts and geographic regions. Concurrently, scientists have conducted assessments to gauge the technology’s precise influence on feed digestibility. This research aims to provide formulators and nutritionists with greater flexibility in their decision-making processes.

Enhancing Feed Digestibility in poultry
In a recent study conducted at the University of Berlin in Germany, researchers undertook a comparative analysis of four treatments: a negative control, two commercial products incorporating phytogenics (referred to as P1 & P2), and a novel technology, NUQO©NEX (NQ). The findings revealed that the NQ treatment not only enhanced the digestibility of nutrients like crude fat, crude protein, and starch but also contributed to increased mineral digestibility, including crude ash, calcium, and phosphorus, when compared to the negative control. The other two solutions also improved the digestibility of certain nutrients and minerals but to a lesser extent than NQ. Notably, the NQ treatment exhibited the most pronounced effects on nutrient and mineral digestibility, resulting in the highest overall performance improvement. In sum, the NQ treatment demonstrated enhanced feed digestibility, ultimately leading to improved performance, in contrast to conventional products relying on phytogenics. This underlines the significance of the formulation’s composition (comprising both phytogenics and phycogenics) and the influence of manufacturing technology (micro-encapsulation) on product stability and release within the digestive system.

Concrete impact on feed costs with a conservative matrix value
The NQ technology underwent extensive testing in various global regions, including Asia, Europe, and Latin America, to evaluate its impact on the performance of laying hens. Additionally, to offer maximum flexibility to nutritionists and formulators, diverse scenarios were examined, involving the application of feed additives either “on top” of the formulation or using a “matrix value” approach, allowing adjustments to the feed formulation to reduce costs by decreasing energy and protein content. Two recent trials were conducted at Kasetsart University in Thailand under the guidance of Professor Yuwares.

In an experiment, the NQ technology was used with a “matrix value” at 75 ppm. Three treatments were tested: 1) an initial control diet [C0], 2) a second treatment that consisted of the same control diet but with reduced energy and protein content (-23 kcal/-0.25% dig.Prot) [NC], and finally, 3) a third treatment was given to animals based on the control diet, with reduced energy and protein content (-23 kcal/-0.25% dig.Prot) along with the NQ technology at 75 ppm [NC+NQ]. In this case as well, the experiment consistently delivered expected results. Applying a matrix to the control diet (NC) adversely affected laying percentage, egg mass, and FCR but did not alter feed intake when compared to the control. Applying NQ technology with a matrix value (NC+NEX) helped to restore layer performance, with the laying percentage even slightly surpassing that of CO.

Beyond performance indicators, additional assessments highlighted the influence of the NQ technology. Researchers observed a decrease in both fatty liver scores and occurrences. Moreover, there was an enhancement in eggshell thickness, whether the technology was used in a diet, with or without a matrix value.

Opt for the latest, science-backed technology to safeguard profits
In the evolving landscape of the egg industry, the NQ technology emerges as a revolutionary solution. By seamlessly combining exclusive ingredients sourced from both plants and algae, it offers a distinctive advantage. What sets this technology apart is its genuine micro-encapsulation method, ensuring the safe and efficient release of active components. Through extensive trials, the remarkable effects on laying hens’ performance, improved feed digestibility, enhanced egg quality, and notable reduction in costs have been demonstrated. NQ technology is not just one more phytogenic feed additive, but rather the most advanced nature-based technology for optimizing laying hens’ performance at competitive cost. It serves as a cornerstone for the future of egg production, delivering unparalleled advantages to producers and championing healthier, more sustainable laying hens’ operations.

Dr. Natthanan Nukitrangsan,
Ph.D, Feed Nutritionist & Technical Consultant
CP BIO

Introduction
Imbalances in the intestinal microbiota are linked to the development of various diseases. As a result, there has been growing interest in using prebiotics, probiotics, and postbiotics to modulate the gut microbiome. Postbiotics refer to substances released or produced through the metabolic activity of microorganisms that exert beneficial effects on the host, either directly or indirectly. Since postbiotics do not contain live microorganisms, the risks typically associated with their consumption are significantly reduced.

In this review, we critically examine current literature on postbiotics, focusing on their mechanisms of action and potential applications in performance trials. We highlight their distinct benefits compared to live probiotics, with the goal of maximizing the effectiveness of postbiotics in target animals. The review explores their key components and advantages related to diet and gut health, emphasizing their role in supporting animal production—particularly in poultry. Relevant studies are referenced to illustrate the immunomodulatory, antimicrobial, anti-inflammatory, and antioxidant properties of postbiotics, as well as their overall impact on productivity and health in animal systems.

How to distinguish postbiotics and their benefits compared to live probiotics?

Postbiotics are metabolic by-products produced by bacteria (exogenous postbiotics). They include non-viable bacterial components and substances such as short-chain fatty acids (SCFAs), peptides, bacteriocins, proteins, and amino acids, all of which can confer health benefits to the host. Unlike probiotics, postbiotics are more stable during feed processing and under various environmental conditions. This enhanced stability, along with their enriched nutrient profile, makes postbiotics a promising alternative to probiotics in animal feed applications.

The use of postbiotics as a tool for improving the health of livestock and poultry shows great promise, owing to their numerous benefits and several advantages over probiotics and prebiotics. As metabolic byproducts or components derived from probiotic bacteria, postbiotics are less sensitive to environmental factors such as temperature, pH, and processing methods (Hossain et al., 2021). This enhanced stability allows them to retain their functional and beneficial properties over time, making them well-suited for diverse applications in animal health and nutrition (Thorakkattu et al., 2022).

Furthermore, we provided the information of postbiotics that can offer more advantages than live probiotics; for instance, (Rafique et al., 2023),

(a) Live probiotics may struggle to adhere to the gut mucosa due to the presence of a mucous layer that limits direct contact between bacteria and the epithelial surface. In contrast, postbiotics can more easily penetrate this mucous layer.
(b) Postbiotics pose no risk of infection from bacterial translocation from the intestinal lumen into the bloodstream, which is particularly important for immunocompromised or susceptible individuals. Additionally, they do not carry the risk of acquiring or transferring antibiotic resistance genes.
(c) Postbiotics offer practical advantages—they are easier to dose, transport, standardize, and store. Moreover, they have significant potential to support intestinal barrier function and may serve as an effective alternative to probiotics (Liu et al., 2023).

The benefits of postbiotics for gut health.
Postbiotics can inhibit the growth of pathogens and strengthen gut barrier function through the action of short-chain fatty acids (SCFAs). For instance, butyrate serves as an energy source for colon epithelial cells and the intestinal mucosa, thereby supporting gut integrity and reducing intestinal permeability.
In addition to enhancing gut barrier function, butyrate plays a role in immunomodulation and exhibits anti-inflammatory effects while helping to improve growth performance, as illustrated in Figure 1.

Figure 1: Functions of postbiotics

Butyric acid has demonstrated in vitro antimicrobial activity against both Gram-positive bacteria (e.g., Enterococcus faecalis, Clostridium perfringens, Streptococcus pneumoniae, Streptococcus suis) and Gram-negative bacteria (e.g., Escherichia coli, Salmonella enterica Typhimurium, Campylobacter jejuni) (Kovenda et al., 2019).

The mode of action of sodium butyrate involves its conversion to butyric acid, which can penetrate bacterial cell walls primarily through diffusion. Once inside the cell, butyrate induces cytoplasmic toxicity by lowering the intracellular pH. This acidification disrupts key metabolic processes, depletes energy reserves, and leads to the excretion of protons (H⁺), which further diffuse into the bacterial cell and contribute to toxicity. The increased proton concentration interferes with ATP synthesis by impairing the bacterial cell’s ability to maintain proton gradients essential for energy production and metabolism. Ultimately, the drop in pH and metabolic disruption result in bacterial cell death (Ahsan et al.,2016).

Maximize the effectiveness of postbiotics in target animals.
Based on researches, postbiotic can be able to target gut-brain axis influence on serotonin to improve growth performance (Sofie et al., 2021; Ishii et al.,2019), gut health and nutrient digestion (Ahmed et al., 2014; Kumar et al., 2014), antimicrobial (Mantziari et al., 2020; Fong et al., 2020), anti-inflammation and Immune-microflora balance (Torino et al., 2015; Miyazawa et al., 2015; Maghsood et al., 2018;) including postbiotic/probiotic as an alternative ATB/ZnO (Ali et al., 2023).

FermNutral® derived from the biological fermentation of the probiotic strain Clostridium butyricum, the main components of the product include amino acids, minerals, and beneficial metabolites classified as postbiotics. Rafique et al. (2023), writing in the Journal of Agriculture & Food Research, reviewed the principal classes of postbiotics with health-promoting effects:

1. Short-chain fatty acids (SCFAs) –
Butyrate supports gut integrity, reduces intestinal permeability, modulates immunity, exerts anti-inflammatory actions, and suppresses pathogens. In broilers, butyrate also raises apparent total‑tract crude‑fat digestibility and apparent metabolizable energy (AME), enhancing overall digestion and nutrient absorption.
2. Antimicrobial peptides (bacteriocins) – These peptides display activity against common pathogens, including Salmonella spp., Staphylococcus aureus, Yersinia enterocolitica, and Escherichia coli.
3. Quorum‑sensing (QS) interference – Certain postbiotics inhibit pathogen biofilm formation by disrupting QS signaling, thereby curbing colonization and persistence.
4. Polysaccharides (e.g., teichoic acids) – Contribute anti‑ inflammatory and antimicrobial effects, further supporting host health.
5. B‑complex vitamins, proteins, and amino acids – Provide additional nutritional and functional benefits that complement the antimicrobial and immunomodulatory actions of other postbiotic fractions.

Postbiotic product in poultry trials
FermNutral (FN)® is a postbiotic product consisting of non-living microorganisms (inactivated bacteria) or their components that provide health benefits to the host. It also includes byproducts of probiotic activity in the gut, such as fermentation metabolites.

The main ingredient is calcium butyrate, which makes up 50% of the product. Other components include short-chain fatty acids (butyric acid, acetic acid, propionic acid), 18 amino acids, vitamins (B1, B2, B5, B6, B12, folic acid, E, and K), and minerals (Ca, Fe, Zn, Na, Mg, P, Mn, Cr).

Based on our trial data and correlated research publications, we can confidently say that FN improves productive performance and reduces feed costs, which contributes to higher profits and effective solutions in animal production.

Typically, we focus on both performance and economic returns in animal production, especially for pigs, poultry, and aquatic species. Through extensive research conducted by CP BIO, we have found that using FN in aquatic animals such as Tilapia, Ruby fish, Penaeus vannamei, and Micropterus salmoides significantly enhances growth performance, feed efficiency, survival rates, and overall economic returns, as shown in Table 1.

Conclusions
FermNutral (FN) is a biological fermentation product derived from the probiotic strain Clostridium butyricum. It primarily contains short-chain fatty acids (SCFAs), especially butyrate, along with amino acids, minerals, and beneficial metabolites acting as postbiotics. Essentially, FN functions through the diet-gut-microbe axis to provide effective animal health solutions. Butyrate mainly supplies energy to the epithelial cells of the colon, improving digestion and nutrient absorption while controlling pathogens, maintaining immune balance, and reducing inflammation. Therefore, the multi-modal actions of FN help support gut function, enhancing animal performance and profitability.

References available on request.